Vimarsana
Biggest News Aggregation in the World

Brian Cheng News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brian Cheng. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brian Cheng Today - Breaking & Trending Today

Analysts on Wall Street Lower Ratings for These 10 Stocks - Vimarsana News

Analysts on Wall Street Lower Ratings for These 10 Stocks

In this article, we will discuss the 10 stocks recently downgraded by analysts.

Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript - Vimarsana News

Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript

Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.

Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript - Vimarsana News

Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript

Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.

JPMorgan says buy this immunology stock primed to rally nearly 40% - Vimarsana News

JPMorgan says buy this immunology stock primed to rally nearly 40%

The biotech firm could emerge as a key player treating autoimmune diseases, JPMorgan said.

Source: cnbc.com
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript - Vimarsana News

Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript

Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.27. Roivant Sciences Ltd.